ASG-TIR2 10 mg

Dual GIP and GLP-1 Receptor Agonist

A novel, first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is synthesized as an analog of native GIP with a C20 fatty diacid component, providing an extended half-life. It demonstrates profound effects in studies examining metabolic homeostasis, fat oxidation, and glucose regulation.

Research Applications

• Metabolic pathway analysis and glucose regulation
• Lipid metabolism and fat oxidation studies
• Synergistic dual-receptor activation research